Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.

Razmy, Ajmal

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. [electronic resource] - Archives of neurology Jan 2004 - 97-102 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

0003-9942

10.1001/archneur.61.1.97 doi


Aged
Benzothiazoles
Bromocriptine--adverse effects
Disorders of Excessive Somnolence--etiology
Dopamine Agonists--adverse effects
Dose-Response Relationship, Drug
Ergot Alkaloids--adverse effects
Female
Humans
Indoles--adverse effects
Male
Middle Aged
Parkinson Disease--drug therapy
Pergolide--adverse effects
Polysomnography
Pramipexole
Prospective Studies
Sleep--drug effects
Thiazoles--adverse effects
Wakefulness--drug effects